Autolus Therapeutics plc ( AUTL) - Key Metrics
AUTL Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.17 | -$0.15 | -$0.09 | -$0.10 |
| 2026Q1 | $0.10 | -$0.27 | -$0.25 | -$0.26 |
| 2025Q4 | $0.09 | -$0.34 | -$0.25 | -$0.34 |
| 2025Q3 | $0.08 | -$0.30 | -$0.26 | -$0.20 |
| 2025Q2 | $0.08 | -$0.18 | -$0.27 | -$0.30 |
AUTL Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -2.67 |
| 2026Q1 | 0% | -1.28 |
| 2025Q4 | 0% | -1.46 |
| 2025Q3 | 0% | -1.36 |
| 2025Q2 | 0% | -3.17 |
AUTL
Price: $2.15
52 week price:
Earnings Per Share: -1.11 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United Kingdom
Volume: 412700
Market Capitalization: 590.8 million